Record title
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study
Record identifier
TN_cdi_proquest_miscellaneous_2599183109
Record permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2599183109
Share
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study
About this item
Full title
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
The lancet oncology, 2021, Vol.22 (12), p.1740-1751
Record Identifier
TN_cdi_proquest_miscellaneous_2599183109
Language
English
Formats
Publication information
Publisher
Subjects
More information
Scope and Contents
Contents
Alternative Titles
Full title
Authors, Artists and Contributors
Author / Creator
Lakhani, Nehal J
Chow, Laura Q M
Gainor, Justin F
LoRusso, Patricia
Lee, Keun-Wook
Chung, Hyun Cheol
Lee, Jeeyun
Bang, Yung-Jue
Hodi, Frank Stephen
Kim, Won Seog
Santana-Davila, Rafael
Fanning, Philip
Squifflet, Pierre
Jin, Feng
Kuo, Tracy C
Wan, Hong I
Pons, Jaume
Randolph, Sophia S
Messersmith, Wells A
Chow, Laura Q M
Gainor, Justin F
LoRusso, Patricia
Lee, Keun-Wook
Chung, Hyun Cheol
Lee, Jeeyun
Bang, Yung-Jue
Hodi, Frank Stephen
Kim, Won Seog
Santana-Davila, Rafael
Fanning, Philip
Squifflet, Pierre
Jin, Feng
Kuo, Tracy C
Wan, Hong I
Pons, Jaume
Randolph, Sophia S
Messersmith, Wells A
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2599183109
Permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2599183109
Other Identifiers
ISSN
E-ISSN
DOI
